Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Justices' Hikma Reasoning May Extend Well Beyond Pharma
In a unanimous victory for the generic drug industry, on June 4 the U.S. Supreme Court reversed the U.S. Court of Appeals for the Federal Circuit's decision in Hikma Pharmaceuticals USA Inc.... To view the full article, register now. Already a…
Broker's call: Emcure Pharma (Buy)
Pune headquartered Emcure Pharmaceuticals is a diversified pharma player focused on developing, manufacturing and marketing a broad range of pharmaceutical products in the domestic/international markets. Emcure's domestic business combines a strong…
Dadachanji group gets back into pharmaceutical glass packaging with Kaisha Pharma
The Dadachanji group has re-entered pharmaceutical glass packaging with the launch of Kaisha Pharma, five years after they exited the Schott Kaisha joint-venture. Serum Institute of India had bought out the Indian partner in Schott Kaisha, in 2021.
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Given Consensus Recommendation of 'Moderate Buy' by Analysts
Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) have received an average recommendation of 'Moderate Buy' from the five analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with…
BioMarin (BMRN) Secured 20% U.S. Royalties on Yuviwel. Is Monetizing a Rival Better than Blocking It?
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has converted a global patent dispute with Ascendis Pharma A/S (NASDAQ:ASND) into a royalty-bearing license for Yuviwel, a once-weekly treatment approved to increase linear growth in children aged 2 years…
Orion Corporation: Acquisition of own shares during week 36, 2026
STOCK EXCHANGE RELEASE – CHANGES IN COMPANY'S OWN SHARES Orion Corporation: Acquisition of own shares during week 36, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The…
Inside The Focus Economy
Tyson Gundersen is CEO of Bureau, designing soundproof office booths for workplaces globally. He writes on workplace design and attention. There was a time when silence was so abundant it had no market value. Silence drifted through open windows…
Bristol Myers Squibb: Still Cheap, Despite What The Chart Says (NYSE:BMY)
Bristol Myers Squibb remains a Strong Buy, trading at a 51% discount to sector median with a compelling risk/reward profile. BMY's growth portfolio delivered 15% YoY revenue growth, offsetting headwinds from Opdivo's decline and upcoming Eliquis…
RPG Life Sciences acquiring Raghava Life Sciences' API, intermediates business for ₹135 crore
RPG Life Sciences is acquiring the active pharmaceutical ingredients (API) and intermediates business of Raghava Life Sciences for ₹135 crore. Only business assets are being acquired and not shares of any entity, RPG Life Sciences said…
Trump's Drug Deals Are Working. Here's What Could Make Them Work Even Better.
President Donald Trump promised lower healthcare costs, and he's bringing lower healthcare costs. This week, Trump announced more voluntary deals with drug manufacturers under which they agreed to cut their U.S. prices to the rates they charge in…
Markets snap four-day losing streak as Fed rate hike fears ease
Equity benchmarks ended a four-session losing streak on Friday, staging a modest recovery on the back of easing concerns over an imminent US Federal Reserve rate hike, even as the week itself closed in the red for the fourth consecutive time. The…
Explore Timekettle W4 Plus: The Ultimate AI Interpreter Earbuds
Timekettle has officially taken the wraps off its W4 Plus AI Interpreter Earbuds at IFA 2026 in Berlin. Serving as a direct follow-up to the W4 platform introduced in 2025, the new semi-in-ear wearable is designed for global business travelers…
Growth Stocks To Follow Now - September 4th
Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Ascendis Pharma A/S, Andersen Group, Tyra Biosciences, Teledyne Technologies, Hamilton Lane, and Jersey Mike's are the seven Growth stocks to watch today, according to…
Abhayrab rabies vaccine batch flagged as substandard in India
India's drug regulator has flagged a batch of widely used rabies vaccine Abhayrab as substandard and potentially spurious after it failed a potency test, a government document seen by Reuters shows. The finding marks the second time…
Pfizer (NYSE:PFE) Downgraded by Wall Street Zen to 'Hold'
Pfizer (NYSE:PFE - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a 'buy' rating to a 'hold' rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports. The Phase 3 Failure That…
Receive a Daily briefing on Pharma Industry News
Get Started